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Objectives. The purpose of this study was to evaluate the 
feasibility, safety and diagnostic accuracy of thallium-201 myocar- 
dial tomography with intravenous adenosine triphosphate (ATP) 
infusion in patients with suspected coronary artery disease. 
Background. Both ATP and adenosine are potent coronary 
vasodilators with a very short half-life. Several studies have 
confirmed that he diagnostic accuracy of adenosine thallium-201 
scintigraphy is comparable tothat with exercise. However, a high 
incidence of side effects, including atrioventricnlar (AV) block, 
has also been reported. Because the appropriate infusion rate for 
ATP has not yet been determined, this agent has not been tested 
in combination with myocardial scintigraphy. 
Methods. The study group included 253 consecutive patients 
who underwent thallium-201 myocardial tomography with ATP 
infusion (0.16 mg/kg body weight per rain for 5 rain). The 
occurrence ofadverse ffects was carefully monitored. Of the 120 
patients with coronary angiography, 76 had significant coronary 
artery disease. Tomographic images were assessed visually and by 
computer-quantified polar maps, and they were compared with 
the results of coronary angiography. 
Results. Although 56% of the patients had some adverse effects, 
they were transient and mild. In all patients, the ATP infusion 
protocol could be completed, and no patient required aminophyl- 
line; AV block occurred in only 2% of the patients. The sensitivity 
and specificity were 88% and 80%, respectively, byvisual analysis 
and 91% and 86%, respectively, bycomputer quantification. 
Conclusions. Thallium tomography with ATP is feasible and 
has a diagnostic value similar to that with adenosine for detecting 
coronary artery disease. In addition, it may have fewer side effects 
than adenosine myocardial tomography. 
(J Am Coil Cardio11995;26:1196-201) 
Both adenosine triphosphate disodium (ATP) and its degra- 
dation product, adenosine, are potent coronary vasodilators 
with a rapid onset of action and a very short half-life. Verani et 
al. (1) first showed that thallium-201 emission computed 
tomography after intravenous infusion of adenosine is valuable 
for the diagnosis of coronary artery diseases. Since then, 
several studies have confirmed that the diagnostic accuracy of 
adenosine thallium-201 scintigraphy is comparable to that of 
thallium-201 scintigraphy with exercise (2-4). Wilson et al. (5) 
showed that intravenous infusions of adenosine at a rate of 
0.14 mg/kg per rain can cause near-maximal coronary hyper- 
emia in most patients. However, ATP has not yet been 
investigated in combination with thallium-201 myocardial to- 
mography, because the infusion rate of ATP that causes 
maximal coronary vasodilation has not been determined, al- 
though the agent has been widely used for the short-term 
therapy for paroxysmal supraventricular tachycardia (6). 
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Moreover, although the effect of ATP is proposed to be mostly 
dependent on its degradation to adenosine (7,8), direct stim- 
ulation of adenosine receptors by ATP itself cannot be fully 
excluded (9-11). In this study we assessed the feasibility, 
safety, arid diagnostic accuracy of pharmacologic oronary 
vasodilation with ATP in combination with thallium-201 scin- 
tigraphy for diagnosing coronary artery disease in patients 
unable to perform an exercise test. Our results show that 
thallium-201 myocardial scintigraphy with ATP may have 
fewer side effects than that with adenosine. 
Methods  
Study patients (Table 1). From September 1992 to August 
1994, 253 consecutive patients (125 men, 128 women with a 
mean age of 68 _+ 11 years [range 38 to 89]) underwent 
thallium-201 myocardial scintigraphy with ATP for evaluation 
of possible coronary artery disease. These patients were judged 
to be physically unable to perform a conventional exercise 
stress test. All patients gave informed consent and the protocol 
was approved by the institutional review board of our hospital. 
The clinical characteristics of the patients are summarized in 
Table 1. 
Exclusion criteria for the study included recent myocardial 
infarction (within 2 weeks of the study), unstable angina, 
@1995 by Ihc American ('olJcgc <~I (a~di~,l~), 0735-1097/95/$9.50 
0735-1097(95)00304-M 
JACC Vol. 26, No. 5 MIYAGAWA ET AL. 1197 
November 1, 1995:1196-201 THALLIUM MYOCARDIAL TOMOGRAPHY WITH ATP INFUSION 
Table 1. Demographic Characteristics of the 253 Patients 
Age (yr) 
Mean _+ SD 67.5 _+ 11.8 
Range 38 - 89 
Gender 
Male 125 (49%) 
Female 128 (51%) 
Previous MI (by ECG) 38 (15%) 
Systemic hypertension 113 (45%) 
Diabetes mellitus 48 (19%) 
Medications 
Nitrates 186 (74%) 
Beta-blockers 103 (41%) 
Calcium antagonists 169 (67%) 
ECG = electrocardiography; MI = myocardial infarction. 
hypotension (systolic blood pressure <90 mm Hg), New York 
Heart Association class IV congestive heart failure, greater 
than first-degree atrioventricular (AV) block and asthma or 
chronic obstructive lung disease. Patients who were receiving 
theophylline, antianginal drugs or dipyridamole had these 
drugs discontinued for 24 h before the test. Caffeine ingestion 
was not allowed for ->12 h before the test. 
Of the 253 patients, 120 (65 men, 55 women, mean age 67 _+ 
9 years) also underwent coronary angiography for determi- 
nation of sensitivity, specificity and predictive accuracy of 
thallium-201 myocardial tomography with ATP. 
ATP infusion protocol. The ATP used in this study was 
supplied by Daiichi Pharm. Corp., Tokyo, as a sterile, isotonic 
aqueous olution at a concentration f 10 mg/ml (2-ml vials). 
Patients were studied in the fasting state in the supine position. 
The solution was infused over 5 min at a constant rate of 
0.16 mg/min per kg body weight, through a peripheral venous 
catheter, with the use of an accurate computerized infusion 
pump system. After 3 rain of infusion, 111 MBq of thallium- 
201 was injected as a bolus into another venous ite and flushed 
with 10 ml of normal saline solution, and the infusion contin- 
ued for an additional 2 min. Three electrocardiographic 
(ECG) leads were continuously monitored throughout the test. 
Vital signs and a 12-lead ECG were recorded at baseline, 
during each minute of infusion and for at least 3 min after the 
ATP infusion. Perfusion imaging was begun at 5 min and again 
at 4 h after ATP infusion. Each patient was carefully moni- 
tored and questioned before, during and after termination of 
ATP infusion for the occurrence of adverse vents. All adverse 
events were graded by physician investigators as mild, moder- 
ate or severe on the basis of clinical severity. 
Thallium.201 myocardial emission computed tomography. 
Thallium-201 myocardial perfusion imaging was performed by 
using a large field of view rotating amma camera (Toshiba 
GCA 901A/SB, Tokyo) equipped with a low energy, high 
resolution collimator and interfaced to a computer (Toshiba 
GMS-550U). Images were acquired by means of a circular 
orbit over an anterior 180 °arc from a 45 o right anterior oblique 
projection to a 45 o left posterior oblique projection. Each of 30 
projections was acquired with the use of a 64 x 64 matrix for 
30 s per projection. 
Tomographic reconstruction was performed by means of a 
standard filtered back-projection technique with a Ramp filter 
to generate transaxial tomograms. No scatter or attenuation 
correction was applied. From these transaxial tomograms, the 
long axis of the left ventricle was identified and the oblique- 
angled tomograms were generated (i.e., the vertical ong-axis, 
the short-axis and the horizontal long-axis lices) (Fig. 1, top). 
Interpretation of tomographic images. Visual analysis of 
the tomographic slices was performed by two experienced 
observers who were unaware of the ECG or coronary angio- 
graphic findings. The slices were displayed sequentially in all 
three cardiac planes to assess myocardial perfusion in each 
vascular territory. The presence or absence of redistribution 
was visually noted in the 4-h images. The vascular territories of 
the three major coronary arteries were assigned as follows: the 
septal and anterior segments corresponded to the left anterior 
descending coronary artery, the inferior and posterior seg- 
ments to the right, and the lateral segments to the left 
circumflex coronary artery. Pure apical defects were consid- 
ered abnormal but were not assigned to any individual coro- 
nary vessel. 
Thallium-201 tomograms were quantified with the use of 
computerized two-dimensional polar (bull's-eye) maps of ra- 
dionuclide activity (12). The distribution of radioactivity was 
determined for each tomographic slice by using the eircumfer- 
emial profile technique. The normalized short-axis circumfer- 
ential profiles were then color coded and displayed as concen- 
tric rings from the cardiac apex to the base. Apical images were 
defined from the short- and vertical long-axis slices and 
displayed in the center of the polar map. Then, the map of each 
patient was statistically compared with a normal data bank 
derived from 18 normal subjects who underwent thallium-201 
myocardial tomography with ATP in our laboratory (including 
healthy volunteers with <5% probability of disease and sub- 
jects with normal angiographic findings). A pixel in a patient's 
polar map was considered abnormal (perfusion defect) if its 
count activity was >2.5 SD below the mean count for the 
corresponding pixel in the normal data bank. The initial polar 
maps obtained after the ATP infusion were used to quantify 
perfusion defects, and focal defects involving >3% of the total 
left ventricular pixels were considered abnormal (Fig. 1, bot- 
tom). 
Coronary angiography. Selective coronary angiography 
was performed with multiple views by using standard tech- 
niques. The mean time interval between coronary angiography 
and thallium-201 scintigraphy was 5 +- 7 days (within 3 weeks). 
All angiograms were interpreted by two experienced angiog- 
raphers without knowledge of the scintigraphic results. The 
severity of coronary stenosis was assessed by caliper measure- 
ments and expressed as percent lumen diameter stenosis. 
Stenoses >50% of the normal umen diameter were consid- 
ered significant. 
Statistical analysis. The following calculations were used: 
Sensitivity % 
= 100 x (True positives)/(True positives + False negatives); 
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Figure 1. Top, Thallium-201 single-photon emission computed tomog- 
raphy with adenosine triphosphate (ATP) in a 65-year-old man with a 
previous myocardial infarction. Representative initial tomographic 
slices (upper ow) demonstrate a perfusion defect in the posteroinfe- 
rior wall that was partially redistributed in the 4-h delayed tomo- 
graphic slices (lower ow). Complete redistribution was also evident in 
the anteroseptal wall and apex. Horizontal = horizontal long axis; 
Short = short axis; Vertical = vertical ong axis. Bottom, Bull's-eye 
polar maps of the initial images (ATP STRESS), 4-h delayed images 
(~DISTRIBUTION) and washout rate of thallium (WASHOUT 
RATE) in this patient. The polar map of the initial images was used 
to quantify perfusion defects. Myocardial perfusion defect size 
(EXTENT) was 43% compared with the normal data bank. The 
coronary angiogram of this patient showed a99% stenosis of the right 
coronary artery and a 90% stenosis of the left anterior descending 
artery. Thallium-201 activity is shown by the color scale (vertical bar), 
from white (100%) to black (0%). Ant. -- anterior; inf. = inferior; 
Lat. = lateral; Sept. = septal. 
Specificity (%) 
= 100 × (True negatives)/(True n gatives + False positives); 
Positive predictive value (%) 
= 100 x (True positives)/(True positives + False positives); 
Negative predictive value (%) 
= 100 X (True negatives)/(True n gatives + False negatives); 
Predictive accuracy (%) 
= 100 x (True positives + True negatives/Total number of 
tests). 
Data are presented as the mean value _+ SD when appro- 
priate. Chi-square analysis and the Student  test were used for 
comparison. A p value < 0.05 was considered significant. 
Results  
Hemodynamic responses (Table 2). The hemodynamic ef- 
fects of intravenous ATP infusion are summarized in Table 2. 
The infusion produced a significant increase in heart rate, a 
decrease in blood pressure and, thereby, no significant change 
in the rate-pressure product. Although systolic and diastolic 
blood pressure returned to baseline values _ 10 mm Hg in 
most patients within 3 min after the end of ATP infusion (68% 
and 86%, respectively), 16 patients (6%) had a paradoxic 
increase in systolic blood pressure and 8 (3%) had a paradoxic 
decrease in heart rate. 
Adverse effects of ATP infusion (Table 3). A total of 226 
adverse events were reported by 141 patients (56%) and no 
events by 112 patients (44%). Table 3 shows the incidence of 
Table 2. Hemodynamic Effects of Adenosine Triphosphate in
253 Patients 
Baseline Peak Effect p Value 
Heart rate (beats/min) 65 -+ 14 78 _+ 14 <0.0001 
Systolic BP (mm Hg) 145 -+ 18 125 _+ 22 <0.0001 
Diastolic BP (mm Hg) 83 -+ 14 73 ± 20 0.012 
Rate-pressure product 9.4 _+ 2.4 9.7 _+ 2.4 0.14 
(beats/min x mmHg x 10 3) 
All values are expressed asmean value _+ SD. BP - blood pressure. 
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Table 3. Adverse Effects of Adenosine Triphosphate Infusion in 
253 Patients 
Patients (no.; %) 
Any adverse effect 141; 56% 
Cardiac effects 
Chest pain 95; 38% 
Dyspnea/SOB 20; 8% 
ST segment depression (>1 ram) 40; 16% 
AV block 6; 2% 
Noncardiac effects 
Headache 18; 7% 
Flushing 16; 6% 
Epigastral discomfort 11; 4% 
Sore throat 10; 4% 
No adverse effects 112; 44% 
AV = Atrioventricular; SOB = shortness of breath. 
those adverse vents that occurred with >2% frequency. The 
frequency of having any adverse vent was significantly higher 
in women (66%) than in men (46%) (p < 0.001). Adverse 
reactions, included dyspnea (8%), headache (7%), flushing 
(6%), epigastral discomfort (4%) and sore throat (4%); 80% 
were clinically graded by investigators as mild, 13% as moder- 
ate and 7% as severe. Chest pain and significant ST segment 
depression (>l-mm flat or downsloping ST segment depres- 
sion at 80 ms after the J point) occurred in 95 (38%) and 40 
(16%) patients, respectively; in this group, 23 patients had both 
chest pain and significant ST depression. Of the 95 patients 
with chest pain, 28 had coronary artery disease; of the 40 
patients with significant ST segment depression, 35 had coro- 
nary artery disease. 
No patient required premature termination of ATP or 
treatment with aminophylline. None died or had prolonged 
chest pain, acute myocardial infarction or ventricular arrhyth- 
mias. Six patients (2%) had AV block during the ATP infusion. 
Three of the six had asymptomatic second-degree AV block 
that resolved promptly within 1 rain of termination of ATP 
infusion; the remaining three patients had first-degree AV 
block. No patient had third-degree AV block. One of the 3 
patients with transient second-degree AV block was one of the 
4 patients in the total group of 253 patients who had first- 
degree AV block before testing. 
Correlation between thallium-201 tomography and coro- 
nary angiography. Of the 120 patients who underwent coro- 
nary angiography, 76 had significant coronary artery disease 
(Table 4). Coronary collateral vessels were observed in 22 
patients. The perfusion defects were classified according to the 
degree of redistribution. Of the 76 patients with significant 
coronary artery disease, 9 had normal thallium-201 images, 38 
had reversible perfusion defects, 12 had fixed defects only and 
17 had both fixed and reversible defects determined by visual 
analysis of tomographic images. 
The overall results are listed in Table 5. The sensitivity and 
specificity were 88% and 80%, respectively, by visual analysis 
and 91% and 86% by computer quantification (p = NS 
comparing the two analyses). Of the six patients with normal 
Table 4. Summary of Coronary Artery Disease (->50% stenosis) in 
120 Patients With Coronary Angiography 
Number of Narrowed Patients Sensitivity by 
Coronary Arteries (no.; %) Quantitative Analysis 
0 44; 37% 
1 48; 40% 43 of 48; 90% 
2 24; 20% 22 of 24; 92% 
3 4; 3% 4 of 4; 100% 
coronary angiograms and abnormal images by quantitative 
analysis, two were thought o have hypertrophic eardiomyop- 
athy by other examinations. The sensitivity, as assessed by 
quantitative analysis, was 90% for patients with one-vessel 
coronary artery disease, 92% for those with two-vessel coro- 
nary artery disease and 100% for patients with three-vessel 
coronary artery disease (Table 4). 
Discuss ion  
As many as 25% to 30% of patients with coronary artery 
disease may have a limited ability to achieve maximal exercise 
stress (13). In patients unable to perform an exercise test, 
pharmacologic coronary vasodilation with dipyridamole has 
been used successfully in combination with thallium-201 scin- 
tigraphy as an alternative method of diagnosis in patients with 
suspected coronary artery disease (13,14). Although dipyrida- 
mole thallium-201 scintigraphy is generally a safe test, it 
frequently causes side effects that at times can be life- 
threatening. Because of the prolonged effect of dipyridamole 
(15 to 30 min when given intravenously), it is often necessary to 
use intravenous aminophylline to reverse the side effects. 
Moreover, because the vasodilative action of dipyridamole is
an indirect result of the elevation of endogenous adenosine 
levels, the degree of effect may vary among patients (15,16). 
Thus, intravenous infusion of adenosine has been proposed 
as a means of achieving directly that which is an indirect effect 
of dipyridamole (1,2). Particular attractive aspects of adeno- 
sine for clinical pharmacologic vasodilation are its rapid onset 
of action and extremely short plasma half-life (<2 s). Several 
investigators (1-4) have reported that the diagnostic accuracy 
of adenosine thallium-201 scintigraphy is comparable to that of 
exercise or dipyridamole thallium-201 scintigraphy. However, 
they (17) have also reported a considerably high incidence of 
side effects, even though these side effects are mild and usually 
resolved within 1 to 2 min after termination of adenosine 
Table 5. Interpretation of Adenosine Triphosphate Thallium 
Imaging in 120 Patients With Coronary Angiography 
Visual Analysis Quantitative Analysis 
Sensitivity 67 of 76; 88% 69 of 76; 91% 
Specificity 35 of 44; 80% 38 of 44; 86% 
Positive predictive alue 67 of 76; 88% 69 of 75; 92% 
Negative predictive alue 35 of 44; 80% 38 of 45; 84% 
Predictive accura~ 102 of 120; 85% 107 of 120; 89% 
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infusion. Among these side effects, the occasional occurrence 
of high degree AV block has attracted much attention. 
Like adenosine, ATP also has a short half-life in plasma 
(<20 s) and is rapidly metabolized as follows: ATP~adenosine 
diphosphate-->adenosine monophosphate~adenosine-* 
inosine-->hypoxanthine-->xanthine--+uric acid~allantoin (10). 
Its degradation product, adenosine, can induce maximal coro- 
nary vasodilation through activation of purine receptors (A~ 
and A 2 membrane adenosine receptors) (18). By using the 
Doppler catheter technique, Wilson et al. (5) found a 4.4-fold 
maximal increase in human coronary blood flow velocity at an 
infusion rate of 0.14 mg/kg per rain of adenosine. Recently, by 
using the same technique, it was reported (19) that the 
intravenous infusion of ATP at a rate >0.15 mg/kg per min was 
able to cause maximal coronary hyperemia similar to that 
caused by adenosine. In addition, ATP has been used to 
terminate paroxysmal supraventricular tachycardia. For that 
purpose, a much higher infusion rate of ATP has been used 
safely (8,20). Kinoshita et al. (21) also reported that here were 
no significant differences in side effects between the rate of 
0.16 and that of 0.18 mg/kg per rain during ATP infusion. 
Safety and feasibility of ATP seintigraphy. Although 56% 
of our patients experienced some adverse ffects, these were 
mostly transient and mild and disappeared soon after termi- 
nation of ATP infusion. Our ATP infusion protocol could be 
completed in all patients and no patient required aminophyl- 
line infusion for reversal of adverse ffects. Cerqueira et al. 
(22) recently summarized the side effects from the Adenosine 
Multicenter Trial Registry (phase III trial), which included 
9,256 patients. According to their summary, 81% of patients 
reported some adverse vents, -20% required ose reduction 
or early termination because of intolerable side effects of 
adenosine, 0.8% required treatment with aminophylline. 
Whereas AV block occurred in 7.6% of their patients with 
adenosine infusion, it occurred in only 2% of our patients with 
ATP infusion. 
Thus, our infusion protocol with ATP may have fewer side 
effects than that with adenosine. These results may be due to 
the breakdown time of ATP in plasma because it is gradually 
degraded to adenosine n route from a peripheral vein (the 
injection site) to the coronary sinus. 
Ischemie ST segment depression during ATP infusion. 
Ischemic ST segment depression occurred in 40 patients 
(16%), of whom 35 (88%) had significant coronary artery 
disease and 33 (83%) had reversible defects by thallium-201 
tomography. Thus, ST segment depression during ATP infu- 
sion seems to be a specific but not sensitive marker of 
reversible defects and significant coronary disease. Nishimura 
et al. (23) reported that the presence of coronary collateral 
vessels and adenosine-induced chest pain were significant 
predictors of ischemic ST segment depression i  their patients 
with both angiographically documented coronary artery dis- 
ease and abnormal perfusion defects on thallium-201 tomog- 
raphy. In our series, 19 patients (32%) with both significant 
coronary artery disease and transient perfusion defects had 
ischemic ST segment depression, whereas 41 (68%) did not. 
The frequency of chest pain was significantly higher in patients 
with ST depression than in those without (63% vs. 34%, p = 
0.03), whereas the frequency of collateral vessels was not. 
Detection of coronary artery disease: clinical utility. The 
sensitivity of thallium-201 tomography with ATP using quan- 
titative analysis was 91% and the specificity 86%; the sensitivity 
was 90% in one-vessel, 92% in two-vessel and 100% in 
three-vessel coronary artery disease. Using a similar quantita- 
tive analysis, Nishimura et al. (24) evaluated adenosine thal- 
lium tomography in 134 patients and reported that the sensi- 
tivity and specificity were 87% and 90%, respectively. Four 
other studies (1,3,4,25) also reported that adenosine thallium 
tomography had a 83% to 92% sensitivity and a 75% to 94% 
specificity for detection of coronary artery disease. Our present 
results obtained with ATP stress are comparable to those 
obtained with adenosine stress or exercise stress. 
Limitations of the study. Some of the limitations of our 
study need to be considered. 1) It is possible that patient 
selection bias may have enhanced the sensitivity of the test by 
including "sicker" patients (26). However, this possibility 
seems unlikely because we excluded patients with acute myo- 
cardial infarction or unstable angina pectoris, and only 15% 
had previous Q-wave myocardial infarction. Also, -63% of the 
patients with significant coronary artery stenosis had one- 
vessel stenosis. Furthermore, this bias would have resulted in a 
lower specificity. 2) We did not use a reinjection method in our 
thallium-201 imaging protocol; therefore, we may have under- 
estimated the fraction of patients with ischemia s assessed by 
visual analysis. 3) We used a mixed gender normal data bank 
for quantitative analysis of perfusion defects. Nishimura et al. 
(27) also used a mixed gender normal data bank for quantita- 
tive analysis of adenosine thallium-201 tomography in 120 
patients. They found that the normalcy rate for detection of 
coronary artery disease was high and comparable between men 
and women. 4) We did not measure the plasma ATP level or 
coronary blood flow. It was very difficult for us to measure local 
concentrations of ATP at the coronary sinus and peripheral 
veins because of the short half-life of ATP. Coronary blood 
flow measurements during various ATP infusion rates at 
various sites are now under way in our laboratory with use of 
the Doppler catheter technique. 
Conclusions. Our results suggest hat thallium-201 myo- 
cardial tomography with intravenous ATP infusion is a feasible 
technique and has a diagnostic value similar to that of intra- 
venous adenosine infusion for detecting coronary artery dis- 
ease in patients who are unable to exercise. In addition, 
thallium-201 scintigraphy with intravenous ATP infusion may 
have fewer side effects than that with intravenous adenosine 
infusion. 
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